Inventor · disambiguated record
Patton E. Garay
Also filed as: GARAY PATTON · GARAY PATTON E
10 granted patents·20 pending applications·296 citations·filing 2005–2022
92Inventor score
Top patents by PatentIndex Score
30 records- 0198US11332518B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2021·Granted May 17, 2022·7 cites·30 claims
- 0298US7645570B2Botulinum toxin screening assaysALLERGAN INC·Filed 2008·Granted Jan 12, 2010·68 cites·20 claims
- 0398US7598027B2Botulinum toxin screening assaysALLERGAN INC·Filed 2005·Granted Oct 6, 2009·61 cites·29 claims
- 0497US11261240B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2020·Granted Mar 1, 2022·7 cites·16 claims
- 0597US8198034B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Jun 12, 2012·63 cites·25 claims
- 0695US10703806B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2017·Granted Jul 7, 2020·10 cites·4 claims
- 0794US9249216B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2012·Granted Feb 2, 2016·23 cites·4 claims
- 0894US8618261B2Immuno-based botulinum toxin serotype A activity assaysESTER FERNANDEZ-SALAS·Filed 2010·Granted Dec 31, 2013·44 cites·2 claims
- 0985US2023279083A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2022·Application pending·0 cites
- 1085US2023235031A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2022·Application pending·0 cites
- 1184US8497081B2Botulinum toxin screening assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Jul 30, 2013·9 cites·5 claims
- 1282US2022144925A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2022·Application pending·0 cites
- 1379US8257914B2Botulinum toxin screening assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Sep 4, 2012·4 cites·4 claims
- 1474US2020392212A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2020·Application pending·0 cites
- 1574US2020369749A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2020·Application pending·0 cites
- 1664US2013040368A1Immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2012·Application pending·0 cites
- 1752US2011070186A1Methods of Treating Cancer Using Growth Factor Retargeted EndopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 1849US2013224178A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopepidasesALLERGAN INC·Filed 2013·Application pending·0 cites
- 1948US2013195838A1Methods of Treating Cancer Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2048US2013230502A1Methods of treating cancer using opiod retargeted endopepidasesALLERGAN INC·Filed 2012·Application pending·0 cites
- 2143US2011070212A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2243US2011064713A1Methods of Treating Cancer Using Opioid Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2343US2011110911A1Methods of Treating Cancer Using Tachykinin Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2442US2012207742A1Treatments Using PSMA Ligand EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2540US2012207743A1Inhibiting Aberrant Blood Vessel Formation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2640US2012207733A1Treating a Disease of Hyperproliferation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2740US2012207704A1Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2840US2012207734A1Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted EndpeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2935US2011070215A1Methods of treating cancer using neurotrophin retargeted endopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 3035US2011070211A1Methods of Treating Cancer Using Galanin Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →